Abdul Mannan Explains How DOACs Can Confuse Lupus Anticoagulant Testing
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, has shared a post on LinkedIn:
“Late on a Friday, Dr. Jones reviewed a DRVVT:
• Screen: prolonged
• Mix: no correction
• Confirm: completely normalised
With a confident grin, he declared: ‘Classic Lupus Anticoagulant.’
Diagnosis: Antiphospholipid Syndrome.
Actually, the patient was on rivaroxaban.
The apparent ‘LA’ was nothing more than a DOAC in disguise, and the confirm reagent just happened to mask the culprit.
Moral of the story
Before calling ‘Eureka!’ in the coagulation lab, always check for anticoagulants. DOACs can mimic lupus anticoagulant and mislead even the most confident interpretation.
Learning point
Pre-analytical details are not small print. They are often the hidden plot twists in coagulation testing.”
For more information, check here.
Don’t miss the latest updates with Hemostasis Today.
-
Sep 19, 2026, 09:26Kerry Taylor-Smith: Cold or Flu? – How to Tell the Difference
-
Sep 19, 2026, 09:13Stand with Bleeding Disorder Patients This World Patient Safety Day – WFH
-
Sep 19, 2026, 09:09Stefanie Dimmeler: How the Lymphatic System Shapes Heart Aging
-
Sep 19, 2026, 08:51Zia Ullah Shah: Advancing Early Diagnosis of Wilson Disease With AI and Biomarkers
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology